HIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal.

<h4>Background</h4>There is now strong evidence that preventive oral antiretroviral therapy can moderately reduce likelihood of HIV infection. This concept is called HIV pre-exposure prophylaxis (PrEP). Premature closures of some previous PrEP clinical trials, secondary to ethical concer...

Full description

Bibliographic Details
Main Authors: Madzouka B Kokolo, Dean A Fergusson, D William Cameron
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21850229/pdf/?tool=EBI
id doaj-dc74887e0452484db3ba5dc2c059eec3
record_format Article
spelling doaj-dc74887e0452484db3ba5dc2c059eec32021-03-04T01:40:52ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-0168e2249710.1371/journal.pone.0022497HIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal.Madzouka B KokoloDean A FergussonD William Cameron<h4>Background</h4>There is now strong evidence that preventive oral antiretroviral therapy can moderately reduce likelihood of HIV infection. This concept is called HIV pre-exposure prophylaxis (PrEP). Premature closures of some previous PrEP clinical trials, secondary to ethical concerns, did not stop research. We aimed to appraise the extent of ethics considerations reporting in PrEP study documents.<h4>Methods</h4>We conducted a systematic quantitative ethics appraisal, grounded in PrEP literature and using eight principles proposed by Ezechiel Emanuel. We developed an a priori checklist of 101 evidence-based ethics items. We obtained protocols for eleven of nineteen clinical controlled studies identified. Two reviewers independently appraised study documents against the checklist. Ethics appraisal was synthesized using adjusted percentages of items reported.<h4>Results</h4>On average, 58% of the 101 ethics items were mentioned or addressed in documents, with variations noted both across studies and across principles. Considerations pertaining to social value were least reported (43% of checklist items, on average) whereas considerations related to informed consent and favorable risk-benefit ratio were most reported (75% of checklist items, on average).<h4>Discussion</h4>Some PrEP studies reportedly address more ethics considerations than others but, overall, ethics considerations reporting could be much improved. While this review does not allow us to comment on the actual execution of HIV PrEP trials, it is a reminder that optimism generated by potentially effective interventions should not overshadow the importance of ethics in research design and development. Improving ethics reporting might improve the perceived value of PrEP research and subsequent data.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21850229/pdf/?tool=EBI
collection DOAJ
language English
format Article
sources DOAJ
author Madzouka B Kokolo
Dean A Fergusson
D William Cameron
spellingShingle Madzouka B Kokolo
Dean A Fergusson
D William Cameron
HIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal.
PLoS ONE
author_facet Madzouka B Kokolo
Dean A Fergusson
D William Cameron
author_sort Madzouka B Kokolo
title HIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal.
title_short HIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal.
title_full HIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal.
title_fullStr HIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal.
title_full_unstemmed HIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal.
title_sort hiv pre-exposure prophylaxis (prep)--a quantitative ethics appraisal.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2011-01-01
description <h4>Background</h4>There is now strong evidence that preventive oral antiretroviral therapy can moderately reduce likelihood of HIV infection. This concept is called HIV pre-exposure prophylaxis (PrEP). Premature closures of some previous PrEP clinical trials, secondary to ethical concerns, did not stop research. We aimed to appraise the extent of ethics considerations reporting in PrEP study documents.<h4>Methods</h4>We conducted a systematic quantitative ethics appraisal, grounded in PrEP literature and using eight principles proposed by Ezechiel Emanuel. We developed an a priori checklist of 101 evidence-based ethics items. We obtained protocols for eleven of nineteen clinical controlled studies identified. Two reviewers independently appraised study documents against the checklist. Ethics appraisal was synthesized using adjusted percentages of items reported.<h4>Results</h4>On average, 58% of the 101 ethics items were mentioned or addressed in documents, with variations noted both across studies and across principles. Considerations pertaining to social value were least reported (43% of checklist items, on average) whereas considerations related to informed consent and favorable risk-benefit ratio were most reported (75% of checklist items, on average).<h4>Discussion</h4>Some PrEP studies reportedly address more ethics considerations than others but, overall, ethics considerations reporting could be much improved. While this review does not allow us to comment on the actual execution of HIV PrEP trials, it is a reminder that optimism generated by potentially effective interventions should not overshadow the importance of ethics in research design and development. Improving ethics reporting might improve the perceived value of PrEP research and subsequent data.
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21850229/pdf/?tool=EBI
work_keys_str_mv AT madzoukabkokolo hivpreexposureprophylaxisprepaquantitativeethicsappraisal
AT deanafergusson hivpreexposureprophylaxisprepaquantitativeethicsappraisal
AT dwilliamcameron hivpreexposureprophylaxisprepaquantitativeethicsappraisal
_version_ 1714809418316513280